[go: up one dir, main page]

US3608593A - Method of filling powders into containers - Google Patents

Method of filling powders into containers Download PDF

Info

Publication number
US3608593A
US3608593A US15269A US3608593DA US3608593A US 3608593 A US3608593 A US 3608593A US 15269 A US15269 A US 15269A US 3608593D A US3608593D A US 3608593DA US 3608593 A US3608593 A US 3608593A
Authority
US
United States
Prior art keywords
powder
diluent
inert
suspension
containers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US15269A
Inventor
Samuel L Mccormick Jr
John J Burke
Arthur R Morstadt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of US3608593A publication Critical patent/US3608593A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/04—Methods of, or means for, filling the material into the containers or receptacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Definitions

  • Powders are filled into bottles, ampoules, vials, syringes, and other containers by suspending the powder in an inert, volatile, liquid diluent, filling the suspension into the container, and evaporating the inert, liquid diluent, leaving the dry powder in the container.
  • the inert, volatile, liquid diluent in which the powder is suspended is one having a boiling point below about 100 C., preferably below about 50 C., and still more preferably below about 30 C.
  • the lower limit for the boiling point of the diluent is controlled only by the necessity of operating under superatmospheric pressure or reduced temperatures to prevent volatilization of diluents boiling below room temperature at atmospheric pressure.
  • This inert, liquid diluent is preferably one in which the powder is essentially insoluble. If a solution of the powder is used rather than a suspension of the powder, there is a greater likelihood of caking occurring when the liquid is evaporated.
  • Volatile diluents are preferred to facilitate diluent removal after the suspension has been added to the container. It will be understood that the diluent must be one that can be removed at a temperature at which the powder is stable. Vigorous removal of the diluent is preferably avoided since this might result in spattering with loss of powder or unsightly splotches of powder on the sides of the container.
  • the diluent employed is one boiling below about 30 C. it will be easily removed by a stream of air or slight vacuum. However, the volatility of such diluents does present other problems. A diluent boiling at about 50 C. is more easily handled but is more difficult to evaporate. Diluents boiling at temperatures up to about 100 C. may require special evaporation procedures, especially if the powder is thermally unstable.
  • Suitable inert, liquid diluents include alkanes such as cyclobutane, n-pentane, isopentane and neopentane; alkenes such as 2-butene, l-pentene, 2-pentene, S-methylbutene-l, and 2-methylbutene-2; alkynes such as lbutyne, 2-butyne, and l-pentyne; dienes such as l,2-butadiene; halogenated hydrocarbons such as methyl chloride, methyl bromide, methylene chloride, ethyl chloride, ethyl bromide, isopropyl chloride, fluorotrichloromethane, and fluorodichloromethane; ethers and expoxides such as diethyl ether, methyl ethyl ether, ethylene oxide and propylene oxide; alcohols such as methanol, ethanol and isopropano
  • diluent to be used will depend upon the properties of the powder being filled. For example, what constitutes an inert diluent will depend upon the types of reactive chemical groups present in the powder. The choice of inert diluent will also be affected by the solubility characteristics and thermal stability of the powder. A skilled chemist or chemical engineer will have no difficulty in selecting a suitable diluent for any given powder.
  • the concentration of powder in the suspension will determine the size container necessary to hold a given amount of powder.
  • the powders are removed from the container by dissolving in a suitable solvent such as water.
  • a suitable solvent such as water.
  • the dry powder usually occupies only a part of the volume of the container. Therefore, suspensions containing on the order of 25 to 30 percent of the powder can be used in the filling operation. In those cases where less free space is needed in the finished container more concentrated suspensions of 50 percent or higher may be used.
  • the only upper limit on the concentration is a practical one controlled by the fluidity and ease of handling of the suspension.
  • the suspension of the powder in the liquid diluent is fluid so that conventional liquid-filling equipment with slight modification may be used to introduce the suspension into the container. In some instances it may be necessary to modify the liquid-filling equipment by providing some means of agitation in the suspension storage tank to prevent settling.
  • the only remaining step is the evaporation of the liquid diluent.
  • This may be done at any pressure under which the liquid diluent can be removed while maintaining the temperature at a level at which the powder is stable.
  • This evaporation may be conducted by passing the filled containers through a heated chamber, either at atmospheric or reduced pressure. Evaporation at atmospheric pressure is preferred. It is also possible to effect the evaporation by blowing warm air over the open mouth of the container.
  • Various methods of evaporating the diluent are well known to those skilled in the art, and any of these methods may be used. The particular method employed is not important to our invention.
  • a particularly useful procedure for evaporating higher boiling diluents at temperatures below their boiling points utilizes an intermittent buildup and release of air pressure in what amounts to a "pumping" effect. This is accomplished by placing the filled containers in a closed evaporation vessel, introducing warm air (at a temperature below the boiling point of the diluent) under a positive pressure, and periodically venting the evaporation vessel.
  • the warm air may be at a pressure below about 15 p.s.i., such as 5 to 10 p.s.i.
  • the venting may be automatically accomplished by having the evaporation vessel equipped with a pressure relief valve to automatically vent at some preset pressure such as 3 to 5 p.s.i.
  • a high-boiling diluent may be evaporated at at temperature well below its boiling point more rapidly than by the use of a steady stream of air at the same temperature.
  • isopropanol can be used as a diluent for cephalothin. It is also possible to use a mixture of isopropanol and some other diluent such as ethylene oxide.
  • EXAMPLE 1 A suspension of powdered cephalothin in a 2:1 mixture of methyl chloride and ethylene oxide was prepared in which one gram of cephalothin was added for each 2.5 cc. of mixed diluent. This suspension was taken up in a 20 cc. syringe with an open-barrel needle which had been previously chilled in a dry ice/acetone bath. The suspension was then injected from the syringe into glass ampoules No. 5888 having a l3-millimeter inside-diameter mouth. An amount of suspension containing 1 g. of cephalothin was introduced into each ampoule. The filled ampoules were dried at 20 C. in a hood under turbulent airflow conditions at atmospheric pressure. The drying required about 15 minutes and left 1 gram of cephalothin in the ampoule.
  • EXAMPLE 2 A suspension of cephalothin was prepared as in example 1 except that the diluent was only methyl chloride. The suspension was taken up in a chilled 20 cc. syringe with an open-barrel needle and was filled into glass ampoules No. 5807 having an 8 mm. inside diameter opening such that the suspension in each ampoule contained 1 gram of cephalothin. The methyl chloride was removed at 25 C. with a warm-air blower in a glove box with a nitrogen purge at atmospheric pressure. Drying under these conditions required about 10 minutes.
  • EXAMPLE 3 A suspension of 1 gram of cephaloridine in 3 cc. of a 9:1 mixture of methyl chloride and ethylene oxide was prepared. Using a chilled 20 cc. syringe with an open-barrel needle, the suspension was filled into glass ampoules No. 5807 at a temperature of C. The methyl chloride/ethylene oxide mixture was evaporated at 20 C. in a glove box with a nitrogen purge at atmospheric pressure. The drying operation required about 10 minutes left 1 gram of cephaloridine in the ampoule.
  • EXAMPLE 4 A suspension containing 1 gram of cephalothin per 3 cc. of isopropanol was filled into No. 5807 glass ampoules using an automatic hand pipette such that each ampoule contained l gram of cephalothin.
  • the ampoules were placed in a closed vessel equipped with an air feed line and a pressure relief valve set to open at 3 p.s.i. Air at 70 C. was fed to the vessel at a rate of 15 cubic feet per hour under a pressure of 10 p.s.i. The relief valve opened about once each second to expel air having a temperature of about 60 C. In this manner the isopropanol was evaporated in 30 minutes to leave 1 gram of dry cephalothin in the ampoule.
  • the powder remaining in the ampoules after evaporation of the diluent was unchanged chemically or physically from that used to prepare the suspensions. Also, the reconstitution (resolution) characteristics of the powders were unchanged. There was no problem of dusting in the operation and no need to clean the ampoules after filling. Because the amount of powder in the suspension was known, the correct amount of suspension could be accurately measured into the ampoule to leave one gram of powder after evaporation of the diluent.
  • a method for filling powders into containers which comprises suspending the powder in an inert, liquid diluent having a boiling point below about C., filling the suspension into the container and evaporating the inert, liquid diluent, leaving the powder in the container.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Powders are filled into bottles, ampoules, vials, syringes, and other containers by suspending the powder in an inert, volatile, liquid diluent, filling the suspension into the container, and evaporating the inert, liquid diluent, leaving the dry powder in the container.

Description

United States Patent Inventors Samuel L. McCormick, Jr.
Indianapolis; John J. Burke, Indianapolis; Arthur R. Morstadt, Speedway, all of Ind.
Appl. No. 15,269
Filed Feb. 27, 1970 Patented Sept. 28, 1971 Assignee Eli Lilly and Company Indianapolis, Ind.
Continuation-impart of application Ser. No. 858,541, Sept. 16, 1969, now abandoned.
METHOD OF FILLING POWDERS INTO CONTAINERS [50] Field of Search 141/1, 4-7, 11, 69, 82, 70; 55/75; 302/14, 66
[5 6] References Cited UNITED STATES PATENTS 449,102 3/1891 Andrews 302/14 1,091,251 3/1914 Stauffer 302/14 1,486,883 3/1924 Halliburton. 302/14 2,235,748 3/1941 Hukill 302/66 2,686,085 8/1954 Odell 302/66 2,889,856 6/1959 Magnuson 302/14 3,381,831 5/1968 Oka 302/14 Primary ExaminerHouston 8. Bell, Jr. Attorneys- Everet F. Smith and Leroy Whitaker ABSTRACT: Powders are filled into bottles, ampoules, vials, syringes, and other containers by suspending the powder in an inert, volatile, liquid diluent, filling the suspension into the container, and evaporating the inert, liquid diluent, leaving the dry powder in the container.
METHOD OF FILLING POWDERS INTO CONTAINERS CROSS-REFERENCE This application is a continuation-impart of our copending application Ser. No. 858,541, filed Sept. 16, 1969, now abandoned.
BACKGROUND OF THE INVENTION Heretofore, the filling of powders into containers has been beset with several problems inherent in the operation. The accuracy of fill was always in question, especially on small, critical-fill volumes. Containers much larger than desired with oversized fill openings were necessary due to the near impossibility of getting the powder into a container with a small opening. The operation was usually very dusty, particularly with low-density powders, necessitating cleanup of the containers and the work area and resulting in losses of the powder.
SUMMARY We have now found that these problems inherent in filling powders into containers can be overcome by a filling process which comprises suspending the powder in an inert, liquid diluent having a boiling point below about 100 C., adding the suspension to the container, and evaporating the inert liquid diluent, leaving the powder in the container. By means of this process powders can be filled in containers having very small openings using conventional liquid filling equipment. Accurate measurement of the powder introduced into the container can be realized, and the presence of the liquid prevents the dusting usually accompanying powder-fill operations.
DESCRIPTION OF THE'PREFERRED EMBODIMENT Our process can be used for the filling of any powder for which a suitable inert, liquid diluent can be found. We expect that the process will find its greatest utility in the filling of pharmaceutical powders into vials, ampoules, and syringes. These types of containers normally have very small openings which make them difficult to fill with powders. Typical of the powders which might be filled by our process are cephalothin, cephaloridine, potassium penicillin G, streptomycin sulfate, phenobarbital sodium, amobarbital sodium, and secobarbital sodium. This list is merely illustrative of the types of the powders that can be filled by our process and is by no means all-inclusive or limiting. The particular powder being filled is unimportant since our invention lies in the method of filling, regardless of the powder being filled.
The inert, volatile, liquid diluent in which the powder is suspended is one having a boiling point below about 100 C., preferably below about 50 C., and still more preferably below about 30 C. The lower limit for the boiling point of the diluent is controlled only by the necessity of operating under superatmospheric pressure or reduced temperatures to prevent volatilization of diluents boiling below room temperature at atmospheric pressure. This inert, liquid diluent is preferably one in which the powder is essentially insoluble. If a solution of the powder is used rather than a suspension of the powder, there is a greater likelihood of caking occurring when the liquid is evaporated. Volatile diluents are preferred to facilitate diluent removal after the suspension has been added to the container. It will be understood that the diluent must be one that can be removed at a temperature at which the powder is stable. Vigorous removal of the diluent is preferably avoided since this might result in spattering with loss of powder or unsightly splotches of powder on the sides of the container.
If the diluent employed is one boiling below about 30 C. it will be easily removed by a stream of air or slight vacuum. However, the volatility of such diluents does present other problems. A diluent boiling at about 50 C. is more easily handled but is more difficult to evaporate. Diluents boiling at temperatures up to about 100 C. may require special evaporation procedures, especially if the powder is thermally unstable.
One such special procedure will be described in some detail below.
Typical examples of suitable inert, liquid diluents include alkanes such as cyclobutane, n-pentane, isopentane and neopentane; alkenes such as 2-butene, l-pentene, 2-pentene, S-methylbutene-l, and 2-methylbutene-2; alkynes such as lbutyne, 2-butyne, and l-pentyne; dienes such as l,2-butadiene; halogenated hydrocarbons such as methyl chloride, methyl bromide, methylene chloride, ethyl chloride, ethyl bromide, isopropyl chloride, fluorotrichloromethane, and fluorodichloromethane; ethers and expoxides such as diethyl ether, methyl ethyl ether, ethylene oxide and propylene oxide; alcohols such as methanol, ethanol and isopropanol; esters such as methyl formate; and inorganic diluents such as sulfur dioxide. It is to be understood that mixtures of these diluents may also be used.
The choice of diluent to be used will depend upon the properties of the powder being filled. For example, what constitutes an inert diluent will depend upon the types of reactive chemical groups present in the powder. The choice of inert diluent will also be affected by the solubility characteristics and thermal stability of the powder. A skilled chemist or chemical engineer will have no difficulty in selecting a suitable diluent for any given powder.
The concentration of powder in the suspension will determine the size container necessary to hold a given amount of powder. In general, in the case of medicinal powders the powders are removed from the container by dissolving in a suitable solvent such as water. In such cases the dry powder usually occupies only a part of the volume of the container. Therefore, suspensions containing on the order of 25 to 30 percent of the powder can be used in the filling operation. In those cases where less free space is needed in the finished container more concentrated suspensions of 50 percent or higher may be used. The only upper limit on the concentration is a practical one controlled by the fluidity and ease of handling of the suspension.
The suspension of the powder in the liquid diluent is fluid so that conventional liquid-filling equipment with slight modification may be used to introduce the suspension into the container. In some instances it may be necessary to modify the liquid-filling equipment by providing some means of agitation in the suspension storage tank to prevent settling.
Once the measured amount of suspension has been added to the container the only remaining step is the evaporation of the liquid diluent. This may be done at any pressure under which the liquid diluent can be removed while maintaining the temperature at a level at which the powder is stable. This evaporation may be conducted by passing the filled containers through a heated chamber, either at atmospheric or reduced pressure. Evaporation at atmospheric pressure is preferred. It is also possible to effect the evaporation by blowing warm air over the open mouth of the container. Various methods of evaporating the diluent are well known to those skilled in the art, and any of these methods may be used. The particular method employed is not important to our invention.
A particularly useful procedure for evaporating higher boiling diluents at temperatures below their boiling points utilizes an intermittent buildup and release of air pressure in what amounts to a "pumping" effect. This is accomplished by placing the filled containers in a closed evaporation vessel, introducing warm air (at a temperature below the boiling point of the diluent) under a positive pressure, and periodically venting the evaporation vessel. The warm air may be at a pressure below about 15 p.s.i., such as 5 to 10 p.s.i. The venting may be automatically accomplished by having the evaporation vessel equipped with a pressure relief valve to automatically vent at some preset pressure such as 3 to 5 p.s.i. By means of such a procedure a high-boiling diluent may be evaporated at at temperature well below its boiling point more rapidly than by the use of a steady stream of air at the same temperature.
The use of such a procedure allows the use of higher boiling diluents with thermally sensitive powders. For example,
isopropanol can be used as a diluent for cephalothin. It is also possible to use a mixture of isopropanol and some other diluent such as ethylene oxide.
Our process will be further illustrated by the following examples.
EXAMPLE 1 A suspension of powdered cephalothin in a 2:1 mixture of methyl chloride and ethylene oxide was prepared in which one gram of cephalothin was added for each 2.5 cc. of mixed diluent. This suspension was taken up in a 20 cc. syringe with an open-barrel needle which had been previously chilled in a dry ice/acetone bath. The suspension was then injected from the syringe into glass ampoules No. 5888 having a l3-millimeter inside-diameter mouth. An amount of suspension containing 1 g. of cephalothin was introduced into each ampoule. The filled ampoules were dried at 20 C. in a hood under turbulent airflow conditions at atmospheric pressure. The drying required about 15 minutes and left 1 gram of cephalothin in the ampoule.
EXAMPLE 2 A suspension of cephalothin was prepared as in example 1 except that the diluent was only methyl chloride. The suspension was taken up in a chilled 20 cc. syringe with an open-barrel needle and was filled into glass ampoules No. 5807 having an 8 mm. inside diameter opening such that the suspension in each ampoule contained 1 gram of cephalothin. The methyl chloride was removed at 25 C. with a warm-air blower in a glove box with a nitrogen purge at atmospheric pressure. Drying under these conditions required about 10 minutes.
EXAMPLE 3 A suspension of 1 gram of cephaloridine in 3 cc. of a 9:1 mixture of methyl chloride and ethylene oxide was prepared. Using a chilled 20 cc. syringe with an open-barrel needle, the suspension was filled into glass ampoules No. 5807 at a temperature of C. The methyl chloride/ethylene oxide mixture was evaporated at 20 C. in a glove box with a nitrogen purge at atmospheric pressure. The drying operation required about 10 minutes left 1 gram of cephaloridine in the ampoule.
EXAMPLE 4 A suspension containing 1 gram of cephalothin per 3 cc. of isopropanol was filled into No. 5807 glass ampoules using an automatic hand pipette such that each ampoule contained l gram of cephalothin. The ampoules were placed in a closed vessel equipped with an air feed line and a pressure relief valve set to open at 3 p.s.i. Air at 70 C. was fed to the vessel at a rate of 15 cubic feet per hour under a pressure of 10 p.s.i. The relief valve opened about once each second to expel air having a temperature of about 60 C. In this manner the isopropanol was evaporated in 30 minutes to leave 1 gram of dry cephalothin in the ampoule.
In all the examples the powder remaining in the ampoules after evaporation of the diluent was unchanged chemically or physically from that used to prepare the suspensions. Also, the reconstitution (resolution) characteristics of the powders were unchanged. There was no problem of dusting in the operation and no need to clean the ampoules after filling. Because the amount of powder in the suspension was known, the correct amount of suspension could be accurately measured into the ampoule to leave one gram of powder after evaporation of the diluent.
We claim:
1. A method for filling powders into containers which comprises suspending the powder in an inert, liquid diluent having a boiling point below about C., filling the suspension into the container and evaporating the inert, liquid diluent, leaving the powder in the container.
2. A method as in claim 1 wherein the inert, liquid diluent has a boiling oint below about 50 C.
A met 0d as in claim 2 wherein the powder is cephaloridine.
4. A method as in claim 2 wherein the powder is cephalothin.
5. A method as in claim 1 wherein the inert, liquid diluent is evaporated by placing the filled container in a closed evaporation vessel, introducing warm air into the vessel under a positive pressure, and periodically venting the vessel.
6. A method as in claim 5 wherein the powder is cephalothin and the inert, liquid diluent is isopropanol.
Disclaimer 3,608,593.-Samuel L. McCormick, JT. and Jahn J. Burke, Indianapolis, and Awthur R. Mowstadt, Speedway, Ind. METHOD OF FILLING POWDERS INTO CONTAINERS. Patent dated Sept. 28, 1971. Disclaimer filed Oct. 6, 1976, by the assignee, Eli Lilly and Company. Hereby enters this disclaimer to all claims of said patent.
[Official Gazette Jan'um'y 11, 1.977.]

Claims (5)

  1. 2. A method as in claim 1 wherein the inert, liquid diluent has a boiling point below about 50* C.
  2. 3. A method as in claim 2 wherein the powder is cephaloridine.
  3. 4. A method as in claim 2 wherein the powder is cephalothin.
  4. 5. A method as in claim 1 wherein the inert, liquid diluent is evaporated by placing the filled container in a closed evaporation vessel, introducing warm air into the vessel under a positive pressure, and periodically venting the vessel.
  5. 6. A method as in claim 5 wherein the powder is cephalothin and the inert, liquid diluent is isopropanol.
US15269A 1970-02-27 1970-02-27 Method of filling powders into containers Expired - Lifetime US3608593A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1526970A 1970-02-27 1970-02-27

Publications (1)

Publication Number Publication Date
US3608593A true US3608593A (en) 1971-09-28

Family

ID=21770469

Family Applications (1)

Application Number Title Priority Date Filing Date
US15269A Expired - Lifetime US3608593A (en) 1970-02-27 1970-02-27 Method of filling powders into containers

Country Status (1)

Country Link
US (1) US3608593A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026292A (en) * 1974-09-17 1977-05-31 The Procter & Gamble Company Tampon having a mensesphilic foam treated with a liquid lubricant
US6554546B2 (en) * 1999-09-29 2003-04-29 Air Pumped Sand & Gravel Apparatus and method for moving and placing granulate
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US449102A (en) * 1891-03-31 Wallace c
US1091251A (en) * 1911-08-21 1914-03-24 San Francisco Salt Refinery Method of transporting salt.
US1486883A (en) * 1922-06-20 1924-03-18 Halliburton Erle Palmer Method of hydrating cement and the like
US2235748A (en) * 1938-07-14 1941-03-18 William V Hukill Method of drying grain
US2686085A (en) * 1950-07-15 1954-08-10 William W Odell Method of conveying or transporting small-size solids
US2889856A (en) * 1957-04-12 1959-06-09 Genevieve I Magnuson Apparatus for methods of filling measured amounts of viscous liquids or finely divided solids
US3381831A (en) * 1966-11-17 1968-05-07 Messrs Mitsubishi Jukogyo Kabu Hydraulic transportation equipment for soluble pulverulent or granular bodies

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US449102A (en) * 1891-03-31 Wallace c
US1091251A (en) * 1911-08-21 1914-03-24 San Francisco Salt Refinery Method of transporting salt.
US1486883A (en) * 1922-06-20 1924-03-18 Halliburton Erle Palmer Method of hydrating cement and the like
US2235748A (en) * 1938-07-14 1941-03-18 William V Hukill Method of drying grain
US2686085A (en) * 1950-07-15 1954-08-10 William W Odell Method of conveying or transporting small-size solids
US2889856A (en) * 1957-04-12 1959-06-09 Genevieve I Magnuson Apparatus for methods of filling measured amounts of viscous liquids or finely divided solids
US3381831A (en) * 1966-11-17 1968-05-07 Messrs Mitsubishi Jukogyo Kabu Hydraulic transportation equipment for soluble pulverulent or granular bodies

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026292A (en) * 1974-09-17 1977-05-31 The Procter & Gamble Company Tampon having a mensesphilic foam treated with a liquid lubricant
US6554546B2 (en) * 1999-09-29 2003-04-29 Air Pumped Sand & Gravel Apparatus and method for moving and placing granulate
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US10799611B2 (en) 2012-06-12 2020-10-13 Ferrosan Medical Devices A/S Dry haemostatic composition
US9999703B2 (en) 2012-06-12 2018-06-19 Ferrosan Medical Devices A/S Dry haemostatic composition
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US10595837B2 (en) 2013-06-21 2020-03-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11103616B2 (en) 2013-12-11 2021-08-31 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Similar Documents

Publication Publication Date Title
US3608593A (en) Method of filling powders into containers
US3484849A (en) Auxiliary transfer device
US1967439A (en) Medicament package and process
US2176042A (en) Container for lyophilic biologically active substances
US2331117A (en) Dispensing apparatus
US2142278A (en) Medicinal carrying tube
BR112016015190B1 (en) ANTIOXIDANT-FREE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD
BE833758A (en) CONTAINER SUCH AS A VIAL, BULB OR SIMILAR, FOR SPRAYING OR INJECTION OF LIQUID OR PULVERULENT PRODUCT
Edwards The vapour pressure of cyclo-trimethylene-trinitramine (cyclonite) and pentaerythritol-tetranitrate
SE406305B (en) DEVICE ON A VESSEL, PRAM OR OTHER LIQUID CONTAINER FOR TRANSPORT AND / OR STORAGE OF LIQUID TRANSFER GASES
US2876818A (en) Polyethylene bottle
GB1534820A (en) Method and apparatus for transferring liquid from a storage container to a vessel
Cosgrove et al. The thermal decomposition of 1, 3, 5-trinitrohexahydro-1, 3, 5-triazine (RDX)
GB1294008A (en) Process for filling powders into containers
US2427786A (en) Apparatus for concentrating drugs
US2727665A (en) Liquid filling of therapeutic substances
GB824702A (en) Thermally insulated bulk storage container
US2199816A (en) Preservation of biologically active substances
US2378815A (en) Production of low temperatures
GB832350A (en) Container for supplemental medication
GB890984A (en) Improvements in or relating to packages
US2340102A (en) Preservation of biologically active and other substances
Burkett A Rapid Method for the Estimation of Alcohols
He et al. Dataset associated with" Particle Size Distribution Dynamics Can Help Constrain the Phase State of Secondary Organic Aerosol"
US2715564A (en) Hydrazine